Histological and molecular features of lipomatous and nonlipomatous adipose tissue in familial partial lipodystrophy caused by LMNA mutations

Clinical Endocrinology

Volumn 76, Issue 6, 2012, Pages 816-824

  Araujo Vilar D ^a   Victoria, B ^a   Gonzalez Mendez B ^a   Barreiro, F ^a   Fernandez Rodriguez B ^b   Cereijo, R ^c   Gallego Escuredo, J M ^c   Villarroya, F ^c   Paneda Menendez A ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; PROTEIN P53;

ADIPOGENESIS; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CD3+ T LYMPHOCYTE; CELL CYCLE REGULATION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FAMILIAL PARTIAL LIPODYSTROPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPOMA; LIPOMATOSIS; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MICROSCOPY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADIPOSE TISSUE; ADULT; AGED; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; FEMALE; HUMANS; LAMIN TYPE A; LIPODYSTROPHY, FAMILIAL PARTIAL; MALE; MIDDLE AGED; MUTATION; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84860113058     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04208.x     Document Type: Article

References (33)

1. Garg, A., (2000) Lipodystrophies. American Journal of Medicine, 108, 143-152.
2. Cao, H., &, Hegele, R.A., (2000) Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Human Molecular Genetics, 9, 109-112.
3. Rusiñol, A.E., &, Sinensky, M.S., (2006) Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors. Journal of Cell Science, 15, 3265-3272.
4. Decaudain, A., Vantyghem, M.C., Guerci, B., et al. (2007) New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome. Journal of Clinical Endocrinology and Metabolism, 92, 4835-4844.
5. Willén, H., Åkerman, M., Dal Cin, P., et al. (1998) Comparison of chromosomal patterns with clinical features in 165 lipomas: a report of the CHAMP Study Group. Cancer Genetics and Cytogenetics, 102, 46-49.
6. Li, F.P., Abramson, D.H., Tarone, R.E., et al. (1997) Hereditary retinoblastoma, lipoma, and second primary cancers. Journal of the National Cancer Institute, 89, 83-84.
7. Larsson, N.G., Tulinius, N.H., Holme, E., et al. (1995) Pathogenetic aspects of the A8344G mutation of mitochondrial DNA associated with MERRF syndrome and multiple symmetric lipomas. Muscle and Nerve, 3, S102-S106.
8. Casali, C., Fabrizi, G.M., Santorelli, F.M., et al. (1999) Mitochondrial G8363A mutation presenting as cerebellar ataxia and lipomas in an Italian family. Neurology, 52, 1103-1104.
9. Dreijerink, K.M.A., Varier, R.A., van Beekum, O., et al. (2009) The multiple endocrine neoplasia type 1 (MEN1) tumour suppressor regulates peroxisome proliferator-activated receptor g-dependent adipocyte differentiation. Molecular and Cellular Biology, 29, 5060-5069.
10. Guallar, J.P., Vilà, M.R., Lõpez-Gallardo, E., et al. (2006) Altered expression of master regulatory genes of adipogenesis in lipomas from patients bearing tRNALys point mutations in mitochondrial DNA. Molecular Genetics and Metabolism, 89, 283-285.
11. Suga, H., Eto, H., Inoue, K., et al. (2009) Cellular and molecular features of lipoma tissue: comparison with normal adipose tissue. British Journal of Dermatology, 161, 819-825.
12. Enerbäck, S., (2010) Human brown adipose tissue. Cell Metabolism, 11, 248-252.
13. Sambrook, J., Fritsch, E.F., &, Maniatis, T., (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York.
14. Hegele, R.A., Cao, H., Anderson, C.M., et al. (2000) Heterogeneity of nuclear Lamin A mutations in Dunnigan-type familial partial lipodystrophy. Journal of Clinical Endocrinology and Metabolism, 85, 3431-3435.
15. Manilal, S., Randles, K.N., Aunac, C., et al. (2004) A lamin A/C beta-strand containing the site of lipodystrophy mutations is a major surface epitope for a new panel of monoclonal antibodies. Biochimica et Biophysica Acta, 1671, 87-92.
16. Abramoff, M.D., Magelhaes, P.J., &, Ram, S.J., (2004) Image processing with ImageJ. Biophotonics International, 11, 36-42.
17. Araújo-Vilar, D., Lattanzi, G., González-Méndez, B., et al. (2009) Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy. Journal of Medical Genetics, 46, 40-48.
18. Guallar, J.P., Gallego-Escuredo, J.M., Domingo, J.C., et al. (2008) Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy. AIDS, 22, 575-584.
19. Araújo-Vilar, D., Loidi, L., Domínguez, F., et al. (2003) Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation. Hormone and Metabolic Research, 35, 29-35.
20. Hirschey, M.D., Shimazu, T., Goetzman, E., et al. (2010) SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature, 464, 121-125.
21. Wojtanik, K.M., Edgemon, K., Viswanadha, S., et al. (2009) The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation. Journal of Lipid Research, 50, 1068-1079.
22. Bourlier, V., &, Bouloumie, A., (2009) Role of macrophage tissue infiltration in obesity and insulin resistance. Diabetes & Metabolism Journal, 35, 251-260.
23. Lagathu, C., Eustace, B., Prot, M., et al. (2007) Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages. Antiviral Therapy, 12, 489-500.
24. Herrero, L., Shapiro, H., Nayer, A., et al. (2010) Inflammation and adipose tissue macrophages in lipodystrophic mice. PNAS, 107, 240-245.
25. Caron, M., Auclair, M., Donadille, B., et al. (2007) Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence. Cell Death and Differentiation, 14, 1759-1767.
26. Broers, J.L.V., Ramaekers, F.C.S., Bonne, G., et al. (2006) Nuclear lamins: laminopathies and their role in premature ageing. Physiological Reviews, 86, 967-1008.
27. Molchadsky, A., Shats, I., Goldfinger, N., et al. (2008) p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner. PLoS ONE, 3, e3707.
28. Yahagi, N., Shimano, H., Matsuzaka, T., et al. (2003) p53 activation in adipocytes of obese mice. The Journal of Biological Chemistry, 278, 25395-25400.
29. Frolov, M.V., &, Dyson, N.J., (2004) Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. Journal of Cell Science, 117, 2173-2181.
30. Chen, P.L., Riley, D.J., Chen, Y., et al. (1996) Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes and Development, 10, 2794-2804.
31. Dorner, D., Vlcek, S., Foeger, N., et al. (2006) Lamina-associated polypeptide 2α regulates cell cycle progression and differentiation via the retinoblastoma-E2F pathway. The Journal of Cell Biology, 173, 83-93.
32. Capanni, C., Mattioli, E., Columbaro, M., et al. (2005) Altered pre-lamin A processing is a common mechanism leading to lipodystrophy. Human Molecular Genetics, 14, 1489-1502.
33. Vigouroux, C., Auclair, M., Dubosclard, E., et al. (2001) Nuclear envelope disorganisation in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene. Journal of Cell Science, 114, 4459-4468.